This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Apollo Endosurgery, Inc.(NasdaqGM:APEN) dropped from S&P TMI Index CI
Apollo Endosurgery, Inc.(NasdaqGM:APEN) dropped from S&P Global BMI Index CI
Apollo Endosurgery, Inc.(NasdaqGM:APEN) dropped from NASDAQ Composite Index CI
Boston Scientific Corporation completed the acquisition of Apollo Endosurgery, Inc. from a group of shareholders. CI
North American Morning Briefing : Stock Futures -2- DJ
North American Morning Briefing : CPI Print Takes -2- DJ
Cowen Downgrades Apollo Endosurgery to Market Perform From Outperform, Adjusts Price Target to $10 From $13 MT
North American Morning Briefing : Futures Dip As a -2- DJ
Stifel Downgrades Apollo Endosurgery to Hold From Buy, Price Target is $10 MT
North American Morning Briefing : Stock Futures -2- DJ
Lake Street Downgrades Apollo Endosurgery to Hold From Buy, Adjusts Price Target to $10 From $14 MT
Sector Update: Health Care Stocks Unable to Complete Tuesday Recovery MT
Sector Update: Health Care Stocks Still Underwater in Tuesday Trade MT
Top Midday Gainers MT
Apollo Endosurgery Shares Hit 52-Week High on Boston Scientific Deal DJ
Boston Scientific Strikes $615 Million Deal to Buy Medical Tech Firm Apollo Endosurgery MT
Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday MT
Sector Update: Health Care MT
Easing Concerns Over China COVID-19 Protests Prompt Quiet Premarket Session for US Equities MT
Top Premarket Gainers MT
Boston Scientific to Acquire Apollo Endosurgery for $615 Million; Apollo Shares Jump MT
Boston Scientific to buy Apollo Endosurgery for $417 million RE
Boston Scientific to Buy Apollo Endosurgery DJ
Boston Scientific to acquire Apollo Endosurgery in $615 mln deal RE
Boston Scientific Corporation entered into a definitive merger agreement to acquire Apollo Endosurgery, Inc. from a group of shareholders for approximately $500 million. CI
Chart Apollo Endosurgery, Inc.
More charts
Apollo Endosurgery, Inc. is a medical technology company, which is focused on the development of medical devices to advance gastrointestinal therapeutic endoscopy. The Company develops and distributes devices that are used by surgeons and gastroenterologists for various procedures related to gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. The Company's products include the OverStitch Endoscopic Suturing System, which enables advanced endoscopic procedures from within the Gastrointestinal tract, or endolumenally, by allowing physicians to suture, especially full-thickness, and secure the approximation of tissue. The X-Tack Endoscopic HeliX Tacking System is a suture-based device designed specifically for closing and healing defects in the lower gastrointestinal tract. The Orbera Intragastric Balloon System is a non-surgical alternative for interventional weight loss.
More about the company
  1. Stock Market
  2. Equities
  3. APEN Stock
  4. News Apollo Endosurgery, Inc.
  5. Easing Concerns Over China COVID-19 Protests Prompt Quiet Premarket Session for US Equities